Cargando…
Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes
Professional antigen-presenting cells (APCs) are potent generators of tumor antigen-specific cytotoxic T lymphocytes (CTLs) for adoptive immunotherapy; however, generation of APCs is cumbersome, expensive, and subject to the tumor microenvironment. Artificial APCs (aAPCs) have been developed as a co...
Autores principales: | Sun, Longhao, Guo, Hao, Jiang, Ruoyu, Lu, Li, Liu, Tong, Zhang, Zhixiang, He, Xianghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951234/ https://www.ncbi.nlm.nih.gov/pubmed/27007051 http://dx.doi.org/10.18632/oncotarget.8198 |
Ejemplares similares
-
AFP
Publicado: (2009) -
Status of AFP
por: Erland, Paula Agnieszka
Publicado: (2019) -
The AFP Project
por: Staszewski, R.
Publicado: (2011) -
Preclinical Studies of the Off-Target Reactivity of AFP(158)-Specific TCR Engineered T Cells
por: Cai, Lun, et al.
Publicado: (2020) -
Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
por: Liu, Ruoyu, et al.
Publicado: (2021)